top of page

HuCCT1 Xenograft Model

Rincon Bio offers efficacy studies using the HuCCT1 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Bile Duct
Derivation:
Ascites of a 56yo male with metastatic intrahepatic cholangiocarcinoma
Mutations:
KRAS, MSH6, TP53
NCI60:
No
Weeks from stratification to termination (average):
5

HuCCT1 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the HuCCT1 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page